WednesdayJun 24, 2026 9:40 am

QualityStocksNewsBreaks – Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians

Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, announced that Atlas Healthcare Physicians, an independent physician association serving managed care populations across Los Angeles and Orange counties, will provide coverage for the company’s Epi+Gen CHD(TM) and PrecisionCHD(TM) tests for eligible members with prior authorization. The coverage expands access to physician-ordered blood tests designed to assess coronary heart disease risk and support diagnosis and personalized treatment planning. Cardio Diagnostics said Epi+Gen CHD(TM) evaluates a patient’s three-year risk of a coronary heart disease event, while PrecisionCHD(TM) helps diagnose coronary heart disease and identify its underlying molecular drivers. The company…

Continue Reading

WednesdayJun 24, 2026 9:20 am

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Engages Nanosoft to Advance ONC010 Development Program

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced a services agreement with Nanosoft Polymers to support development of ONC010, the company’s lead nanoparticle-formulated PNKP inhibitor. Under the agreement, Nanosoft will provide polymer process development, analytical characterization, formulation optimization, scale-up support and technology transfer services for Onco’s proprietary PEO-PBCL polymer platform as the program advances through IND-enabling development and preparation for future clinical studies. The collaboration is intended to strengthen the manufacturing and formulation foundation of ONC010 by establishing scalable polymer production processes, enhancing analytical methods and…

Continue Reading

WednesdayJun 24, 2026 9:00 am

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Expands Heidelberg R&D Facilities To Support Drug Development Pipeline

VERAXA Biotech (NASDAQ: VRXA) an emerging developer of novel cancer therapies, announced it has expanded its laboratory footprint at its existing research and development site in Heidelberg, Germany, under a previously executed long-term lease agreement. The additional space will support planned growth of the company’s R&D team, installation of new laboratory equipment and completion of infrastructure needed to advance future development activities. VERAXA said the expansion aligns with efforts to advance its growing portfolio of proprietary and partnered oncology programs from discovery-stage research toward early clinical development. The company’s pipeline is centered on its BiTAC platform, including BiTAC-TCE and BiTAC-ADC…

Continue Reading

WednesdayJun 24, 2026 9:00 am

Greenland Mines Ltd. (NASDAQ: GRML) Is ‘One to Watch’

Greenland Mines’ flagship Skaergaard Project hosts an NI 43-101 Mineral Resource estimate containing 11.4 million ounces PdEq in the Indicated category and 14.1 million ounces PdEq in the Inferred category. The pending acquisition of the Sarfartoq Project would add an advanced rare earth asset with a historical resource estimate, extensive drilling history and exposure to magnet rare earth elements including neodymium and praseodymium. The company’s relationship with Neo Performance Materials includes an offtake arrangement covering up to 60% of future Sarfartoq production, subject to completion of the acquisition and future project development. Greenland Mines is pursuing a North Atlantic critical…

Continue Reading

TuesdayJun 23, 2026 12:10 pm

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Expands WiSA Technology Into New Goldhorn Home Audio Systems

Datavault AI (NASDAQ: DVLT) through its Acoustic Sciences division's WiSA Technologies, announced that its WiSA E Enterprise wireless audio module has been integrated into Goldhorn's new Goho LS7 2.0 and 5.1 home audio and karaoke systems. The systems feature 4K Ultra HD projectors and are designed to deliver high-definition stereo and immersive 5.1 surround sound using WiSA's wireless audio transmission technology, with products now available in China. The launch expands WiSA's presence beyond its traditional markets and highlights the scalability of its wireless audio platform. Datavault AI said its WiSA E technology is designed to provide secure, low-latency, high-definition multi-channel…

Continue Reading

TuesdayJun 23, 2026 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Announces Another Infrastructure Milestone Amid Advancements Toward Commissioning of Montauban Project Site

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, recently received the delivery of a propane-fired tilting furnace at its Montauban Project to support on-site melting and casting of gold and silver into doré bars The furnace will form part of the company’s planned circuit for recovering precious metals from permitted tailings material and is a crucial milestone as the company moves to operationalize the facility ESGold has received – and continues to receive – infrastructure and…

Continue Reading

TuesdayJun 23, 2026 10:34 am

QualityStocksNewsBreaks – Hallmark Venture Group, Inc. (OTC: HLLK) Completes Drone Technology Acquisition, Transitions to Operating Business 

Hallmark Venture Group (OTC: HLLK)  announced the completion of a strategic transaction that transforms the company from a shell entity into an operating drone technology business focused on unmanned aerial systems, defense technology and commercial applications. Through the acquisition of a worldwide drone technology platform from South Korea-based Sundori Drone Co., Ltd., the company obtained proprietary technology, software, AI and machine-learning assets, technical documentation and commercialization rights tied to 12 Korean patents, while also securing ongoing engineering support and collaboration agreements. The transaction coincides with a change of control under which EQUORIX, LLC became Hallmark Venture Group’s controlling shareholder and established a new business strategy centered on drone…

Continue Reading

TuesdayJun 23, 2026 10:30 am

The $410 Billion Drug Delivery Revolution: Why Drug Delivery May Be the Next Major Frontier in Oncology Innovation

The rapidly expanding nanomedicine and advanced drug-delivery market is attracting growing attention as pharmaceutical companies seek ways to improve therapeutic performance without relying solely on costly new drug discovery programs. By addressing challenges such as poor bioavailability, inconsistent pharmacokinetics and limited tumor penetration, nanotechnology-based delivery systems may unlock additional value from existing oncology drugs. Oncotelic Therapeutics' Deciparticle(TM) platform and Sapu003 program illustrate how innovative drug delivery approaches could help reshape the future of cancer treatment. The search for new cancer therapies has traditionally focused on discovering entirely new drug candidates. While this approach has produced important breakthroughs, it is also…

Continue Reading

TuesdayJun 23, 2026 9:47 am

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on DNA Repair Cancer Therapies 

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.  Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced its inclusion in a BioMedWire editorial examining the growing market for DNA Damage Response inhibitor (“DDRi”) therapies and the next generation of cancer treatments targeting DNA repair pathways. The article highlights the company’s lead candidate, ONC010(TM), a nanoparticle-encapsulated PNKP inhibitor designed to target a key DNA repair enzyme involved in multiple repair mechanisms, positioning Onco-Innovations among emerging developers seeking to advance new synthetic lethality approaches in precision oncology. To view the full press release, visit https://ibn.fm/KofFy About Onco-Innovations Limited Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment,…

Continue Reading

TuesdayJun 23, 2026 9:45 am

Greenland Energy Company (NASDAQ: GLND) Advances Jameson Project as Greenland Pursues Greater Economic Self-Sufficiency

GLND is advancing exploration at the Jameson Project, one of Greenland's most prospective yet historically underexplored resource regions The company is focused on unlocking economic opportunities that could support job creation, infrastructure development, and long-term revenue generation These developments align with a broader vision: empowering Greenland's path toward greater economic independence through responsible resource development Greenland Energy (NASDAQ: GLND) is positioning itself at the intersection of one of the Arctic’s most compelling economic opportunities. Through the company’s Jameson Project in East Greenland, it is pursuing resource exploration in an area that has long attracted geological interest but has seen only…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered